Navigation Links
Winner Medical Reports Second Quarter Fiscal 2009 Results
Date:5/13/2009

SHENZHEN, China, May 13 /PRNewswire-Asia/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG) ("Winner Medical", or the "Company"), today reported unaudited financial results for the second quarter ended March 31, 2009. The Company's results are detailed in its form 10-Q, filed today with the United States Securities and Exchange Commission.

    Second Quarter 2009 Highlights
    -- Total net sales revenue increased by 15.31% over the second quarter of
       fiscal 2008 to $20.63 million
    -- Gross profit increased by 46.81% over the second quarter of fiscal 2008
       to $5.80 million
    -- Operating income increased by 356.30% over the second quarter of fiscal
       2008 to $2.10 million
    -- Net income increased by 188.42% over the second quarter of fiscal 2008
       to $1.64 million
    -- Net income per share for the second quarter of 2009 was $0.04 per basic
       and diluted share, compared to $0.01 per basic and diluted share for
       the second quarter of fiscal 2008

Jianquan Li, Chairman and Chief Executive Officer of Winner Medical, commented, "We are pleased to announce a strong quarter of increases in sales and net profit. The sales growth was driven by increased orders of our products, particularly from customers in the US. We also improved gross margin and net margin in the second quarter through implementing cost control measures and equipment technical improvements that optimize production efficiency."

Mr. Li continued, "However, looking into the future, the current economic crisis has created great uncertainties on the future market demand and the price level of our products. Thus, considering the related risks, we think the second half of fiscal year 2009 will be tough, and we decide to lower our fiscal year 2009 guidance to an estimate of 15% to 18% increase in net sales from last fiscal year."

Second Quarter 2009 Unaudited Financial Results

Revenue: Winner Medical reported net sales revenue of $20.63 million, a 15.31% increase over the second quarter of fiscal 2008. Healthy revenue growth was mainly due to strong demand, particularly in North and South America; revenue from North and South America was approximately $4.03 million for the second quarter of fiscal 2009, an increase of 158.37% compared to the same period in 2008. The North and South American market accounted for 19.53% of total revenue for the quarter ended March 31, 2009.

Gross Profit: For the second quarter of fiscal 2009, gross profit was $5.80 million, an increase of 46.81% over $3.95 million in the same period of fiscal 2008. Gross margin was 28.13%, versus 22.09% achieved in the second quarter of fiscal 2008. The increase in gross margin was mainly due to the unit product cost decrease as a result of better economies of scale; the improvement of the Company's cost control, equipment technical improvement and lean production management that increased production efficiency and reduced production waste; and the decrease of material purchasing price as the Company combined individual purchases by each subsidiary into larger scale orders to create more bargaining power.

Operating Expenses: Selling, general and administrative expenses increased by 15.68% to $3.87 million in the second quarter of fiscal 2009, from $3.34 million in the first quarter of fiscal 2008. During this quarter, the increase in operating expenses was mainly due to the increased provision for decline in value of inventory, increase in reserve for fixed assets impairment and bad debts, increase in salary and welfare for the management and administrative staff, increase in research and development expenses, and increase in related administrative expenses such as depreciation and amortization for Winner Medical (Huanggang) Co., Ltd.

Operating Income: During the period, operating income was $2.10 million, an increase of 356.30% compared with $0.46 million of the same quarter of 2008. The increase was mainly attributed to decreased export transportation fees, economies of scale related to higher sales revenue, and improved production management to reduce manufacture cost.

Income Taxes: The income tax provision for the second quarter of fiscal 2009 was $460,000, up from -$223,000 for the same period in fiscal 2008. The increase in tax provision was mainly due to a change in tax rate for the Company's subsidiaries in China as a result of the Chinese income tax reform that came into effect on January 1, 2008, and the write off for over-provision of income taxes in the second fiscal quarter of 2008.

Net income: Net income increased by 188.42% to $1.64 million, or $0.04 per basic and diluted share, compared to net income of $0.57 million, or $0.01 per basic and diluted share, for the second quarter of last fiscal year. This increase can be attributed to higher gross margin during the three months ended March 31, 2009 as compared with the same period last year, the decrease in transportation expenses, and improved production management to reduce manufacture cost.

Six Months Ended March 31, 2009 Unaudited Financial Results

Revenue: Winner Medical reported net sales revenue of $46.36 million, a 24.57% increase over the six months ended March 31, 2009. Healthy revenue growth was mainly due to strong demand, particularly in North and South America; revenue from North and South America was approximately $8.99 million for the six months ended March 31, 2009, an increase of 126.56% compared to the same period in 2008. The North and South American market accounted for 19.39% of total revenue for the six months ended March 31, 2009.

Gross Profit: For the six months ended March 31, 2009, gross profit was $12.41 million, an increase of 41.76% over $8.75 million in the same period of fiscal 2008. Gross margin was 26.76%, versus 23.52% achieved in the six months ended March 31, 2009. The increase in gross margin was mainly due to the unit product cost decrease as a result of better economies of scale, and the improvement of the Company's cost control, equipment technical improvement and lean production management that increased production efficiency and reduced production waste; and the decrease of material purchasing price as the Company combined individual purchases by each subsidiary into larger scale orders to create more bargaining power.

Operating Expenses: Selling, general and administrative expenses increased by 20.19% to $8.32 million during the six months ended March 31, 2009, from $6.93 million during the six months ended March 31, 2008. The increase in operating expenses was mainly due to the increased provision for decline in value of inventory, increase in research and development expenses, increase in salary and welfare for the management and administrative staff, and increase in related administrative expenses such as depreciation and amortization for Winner Medical (Huanggang) Co., Ltd.

Operating Income: During the period, operating income was $3.84 million, an increase of 122.58% compared with $1.73 million of the same period of 2008. The increase was mainly attributed to decreased export transportation fees, economies of scale related to higher sales revenue, and improved production management to reduce manufacture cost.

Income Taxes: The income tax provision for the six months ended March 31, 2009 was $720,000, up from -$159,000 for the same period in fiscal 2008. The increase in tax provision was mainly due to a change in tax rate for the Company's subsidiaries in China as a result of the Chinese Income Tax reform that came into effect on January 1, 2008, and the write off for over-provision of income taxes in the second fiscal quarter of 2008.

Net income: Net income increased by 80.08% to $3.12 million, or $0.07 per basic and diluted share, compared to net income of $1.73 million, or $0.04 per basic and diluted share, for the same period of last fiscal year. This increase can be attributed to higher gross margin during the six months ended March 31, 2009 as compared with the same period last year, the decrease in transportation expenses, and improved production management to reduce manufacture cost.

Balance Sheet

Cash and cash equivalents as of March 31, 2009 was approximately $8.12 million, compared with $6.46 million as of September 30, 2008. The Company's working capital as of March 31, 2009 was $17.40 million compared with $12.37 million as of September 30, 2008. Net operating cash flow during the six months ended December 31, 2008 was $6.24 million, an increase of $4.42 million compared with the same period in fiscal 2008.

Second Quarter 2009 Operational Highlights

Medical care, Wound care and Home care products in Export Markets

North and South America - Revenue from customers in North and South America was approximately $4.03 million for the three months ended March 31, 2009, an increase of 158.37% compared to the same period last year. North and South America accounted for 19.53% of total revenue for the three months ended March 31, 2009. The Company has been gradually shifting resources and services to focus on the larger-sized customer segment and successfully attained a higher order volume from existing customers, especially in the United States. As a result, it expects revenue from these larger customers to increase in the future.

Europe - Revenue from European customers was approximately $8.45 million for the second quarter of fiscal 2009, an increase of 4.54% compared to the same period last year. Europe accounted for 40.97% of total revenue for the second quarter of fiscal 2009. The Company has adopted the same strategy in Europe as it has in North and South America: gradually shifting resources and services to focus on the larger-sized customer segment. As a result, it expects revenue from these larger customers to increase in the future.

Medical care, Wound care and Home care products in China

Winner Medical has gradually refined its domestic sales strategies by reducing raw material sales in China and expanding sales of finished products in the domestic market. As a result, sales revenue from China was $3.88 million for the three months ended March 31, 2009, against $2.72 million in the same period last year, an increase of 42.60%.

PurCotton:

In the second quarter of fiscal 2009, PurCotton sales of the Company grew steadily. The Company has $1,108,000 in raw material sales in the second quarter of fiscal 2009, an increase of 31.43% compared with last quarter. The PurCotton sales were mainly to customers in China, Japan, and the U.S. At the same time, the Company is in the stage of processing trial orders of PurCotton finished medical products, such as operation room towels and sponges, with customers in North America and Europe.

Winner Medical believes that demand for PurCotton will grow steadily. While it will be necessary to build education levels and cultivate interest in the short term, Winner Medical is confident in its mid- to long-term growth potential and steady progress has been made to expand the sales revenue.

2009 Guidance

Considering the uncertainties and risks on future market demand and price level due to the economic crisis, the Company lowers its estimate that revenue in fiscal year 2009 will range from $98.33 million to $100.90 million, an increase of 15% to 18% compared to fiscal year of 2008.

Conference Call

Winner Medical senior management will host a conference call at 5am (Pacific)/ 8am (Eastern)/ 8pm (Shenzhen/ Hong Kong) on Thursday, May 14, 2009 to discuss its 2008/09 second quarter results and recent business developments. The conference call can be accessed by calling 866-713-8562 (US), 10-800-130-0399 (South China), 10-800-152-1490 (North China), 800-96-3844 (HK), or +1-617-597-5310 (International); Passcode: 11608372. A telephone replay will be available shortly after the conclusion of the call and will be accessible through May 21, 2009 by calling 888-286-8010 (US) or +1-617-801-6888 (International); Passcode: 62843801.

About Winner Medical

Winner Medical is a leading manufacturer in the medical dressing industry (medical and wound care products) in China. Headquartered in Shenzhen, the Company has eight wholly owned manufacturing and distribution facilities, four joint-venture factories and over 5,000 employees. The Company engages in the manufacture, sale, research, and development of medical care products, wound care products, home care products and PurCotton products, a nonwoven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the U.S. and Japan serving as the top three markets. The Company currently holds 50 patents and patent applications in various products and manufacturing processes and is one of the few Chinese companies licensed with the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the U.S. market. To learn more about Winner Medical, visit Winner Medical's web site http://www.winnermedical.com .

Forward-Looking Statements

This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.

    Investor Relations Contacts:

     Peng Zhai
     Assistant Manager, Investor Relations
     Winner Medical Group Inc.
     Tel:   +86-755-2806-6858
     Email: peng.zhai@winnermedical.com



    Winner Medical Group Inc.
    Consolidated Statements of Income and Comprehensive Income

                               Three months ended        Six months ended
                                    March 31                  March 31
                                2009         2008         2009        2008
                            (Unaudited)  (Unaudited)  (Unaudited)  (Unaudited)
                                US$          US$          US$         US$

    Net sales               20,627,146   17,888,303   46,357,420   37,213,902

    Cost of sales          (14,825,262) (13,936,502) (33,952,140) (28,462,520)
    Gross profit             5,801,884    3,951,801   12,405,280    8,751,382

    Other operating
     income, net               406,285       72,472      891,249      437,555
    Exchange difference, net  (244,685)    (223,352)  (1,129,697)    (536,884)
    Selling, general and
     administrative
     expenses               (3,864,748)  (3,341,351)  (8,323,274)  (6,925,171)

    Income from operations   2,098,736      459,570    3,843,558    1,726,882
    Interest income             11,303        8,259       23,819       18,737
    Interest expense          (118,647)    (138,206)    (327,056)    (238,865)
    Equity in earnings of
     50 percent or less
     owned persons             133,262         (564)     223,138       23,965
    Income before income
     taxes and minority
     interests               2,124,654      329,059    3,763,459    1,530,719

    Income taxes              (459,537)     223,441     (719,665)     158,584
    Income before minority
     interests               1,665,117      552,500    3,043,794    1,689,303

    Minority interests         (20,828)      17,728       75,379       43,001
    Net income               1,644,289      570,228    3,119,173    1,732,304

    Other comprehensive
     income
    Foreign currency
     translation
     difference                 42,540    2,667,997     (125,142)   4,339,872

    Comprehensive income     1,686,829    3,238,225    2,994,031    6,072,176

    Net income per share
      - basic                     0.04         0.01         0.07         0.04
      - diluted                   0.04         0.01         0.07         0.04

    Weighted average common
     stock outstanding
      - basic               44,727,171   44,727,171   44,727,171   44,727,171
      - diluted             44,962,369   44,864,313   44,989,693   44,864,313



    Winner Medical Group Inc.
    Consolidated Balance Sheets
                                                      March 31   September 30
                                                        2009         2008
                                                    (Unaudited)  (Unaudited)
                                                        US$          US$
                                ASSETS
    Current assets:
      Cash and cash equivalents                      8,115,362     6,462,505
      Restricted bank deposits                          88,616       126,749
      Accounts receivable, less allowances
       for doubtful accounts of US$75,641
       and US$100,964 at March 31, 2009 and
       September 30, 2008, respectively             10,398,347    13,516,688
      Amounts due from affiliated companies            165,684       349,359
      Inventories                                   14,880,550    15,839,587
      Prepaid expenses and other
       current assets                                4,193,485     4,734,503
      Income taxes recoverable                          38,915        99,126
      Deferred tax assets                              237,040       207,798
          Total current assets                      38,117,999    41,336,315
    Property, plant and equipment, net              56,506,544    57,937,881
    Held-for-sale asset                                     --       607,423
    Investment in equity investees                   1,600,233     1,518,848
    Intangible assets, net                             117,025       126,141
    Non-current restricted bank deposits               158,189            --
    Prepaid expenses and other receivable               65,829       233,203
    Deferred tax assets                                227,340       158,280
          Total assets                              96,793,159   101,918,091

                 LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
      Short-term bank loans                         10,537,018    15,033,073
      Accounts payable                               4,232,792     8,271,926
      Accrued payroll and employee benefits          1,786,622     1,891,410
      Customer deposits                                694,781       458,303
      Other accrued liabilities                      2,158,541     2,518,326
      Amounts due to affiliated companies                6,047       136,481
      Income taxes payable                           1,303,710       656,550
          Total current liabilities                 20,719,511    28,966,069
    Deferred tax liabilities                            41,857        41,965
          Total liabilities                         20,761,368    29,008,034

    Commitments and contingencies
                                                        72,927       148,306
    Minority interests

    Stockholders' equity:
      Common stock, par value $0.001 per share;
       authorized 495,000,000, issued and
       outstanding March 31, 2009 - 44,727,171
       shares; September 30, 2008 - 44,727,171
       shares                                           44,727        44,727
    Additional paid-in capital                      31,046,409    30,843,327
    Retained earnings                               30,803,057    28,791,259
    Statutory reserves                               3,412,809     2,305,434
    Accumulated other comprehensive income          10,651,862    10,777,004
    Total stockholders' equity                      75,958,864    72,761,751
         Total liabilities and
          stockholders' equity                      96,793,159   101,918,091


'/>"/>
SOURCE Winner Medical Group Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Alzheimers Foundation of America Announces 2009 College Scholarship Winner
2. FDA Award Winner Joins CanRegs US Team
3. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
4. 17th Annual Komen Pittsburgh Race for the Cure(R) 5K Winners Announced
5. AANS/CNS and BrainLAB Announce Winner of 2009 BrainLAB Community Neurosurgery Award
6. PartsSource Named Team NEO Winner for 2009
7. Video: CVS/pharmacy Pays Tribute to Caregivers and Announces Winners of the For All the Ways You Care Contest
8. Winner of 2009 CURE Magazine Extraordinary Healer Award Announced
9. American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners
10. Pennsylvania Dental Association Announces Winners of Annual Statewide Third-Grade Student Poster Contest
11. Children Emerge as Winners in Twitter Challenge Between Ashton Kutcher and CNN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd ... sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers ... and Walk and 1-mile walk were held to increase awareness about Lyme disease ...
(Date:4/29/2016)... ... 2016 , ... Spine Team Texas, a comprehensive spine physician group specializing in ... physicians has been invited to be a featured speaker at the Texas Society of ... April 30, 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of ... improve smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the ... to learn more about the options currently available to them and which ones might ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
Breaking Medicine Technology: